Clinical trial
Effects of Sublingual Immunotherapy on Grasspollen Allergy
NCT00150514 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00150514 |
|---|---|
| Title | Effects of Sublingual Immunotherapy on Grasspollen Allergy |
| Official title | A Placebo Controlled, Double-Blind, Randomised Study to Assess Efficacy of Sublingual Immunotherapy in Patients With Grass Pollen Allergy Through Assessment of Its Immunological Effects on the Mucosal Tissue of the Nose. |
| Lead sponsor | Radboud University Medical Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hayfever |
| Intervention type | Drug, Procedure |
| Interventions | Oralgen, Nasal biopsy, Nasal washing, Peak nasal inspiratory flow |
| Enrollment | 38 |
| Start date | Jan 1, 2002 |
| Completion | Dec 1, 2006 |
| First posted | Sep 8, 2005 |
| Last update posted | Sep 8, 2005 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: